Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Vaxil Bio Ltd V.VXL

Alternate Symbol(s):  VXLLF

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.


TSXV:VXL - Post by User

Bullboard Posts
Post by Snakebite18on Mar 29, 2020 5:06pm
176 Views
Post# 30858110

Due diligence

Due diligence Don't want to be the "Debbie Downer" here but be careful here. Let's remember this stock wasn't even on the radar until this happened and was under a nickel for more than a year. Flavour of week can make and break you in the blink of eye. This is a fairly small company with only about 50 employees compared to companies like Johnson & Johnson who are worth hundreds of billions of dollars and employ 130,000 + people and make the money to back their stock price. I like this stock going forward, doing good things with there research and development and patents but there still a long way from being a dollar or more stock. Of course, saying that, with a couple good news releases and a good push up, who knows. After all this is Venture Exchange ( Canada's O.T.C)
Bullboard Posts